Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-26
DOI
10.3389/fmicb.2020.01434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Three Emerging Coronaviruses in Two Decades
- (2020) Jeannette Guarner AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Is COVID-19 receiving ADE from other coronaviruses?
- (2020) Jason A. Tetro MICROBES AND INFECTION
- The arms race between bacteria and their phage foes
- (2020) Hannah G. Hampton et al. NATURE
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
- (2020) Shukho Kim et al. Journal of Global Antimicrobial Resistance
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Safety of bacteriophage therapy in severe Staphylococcus aureus infection
- (2020) Aleksandra Petrovic Fabijan et al. Nature Microbiology
- Bacteriophages and Lysins in Biofilm Control
- (2020) Marzanna Łusiak-Szelachowska et al. VIROLOGICA SINICA
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Molecular immune pathogenesis and diagnosis of COVID-19
- (2020) Xiaowei Li et al. Journal of Pharmaceutical Analysis
- Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species
- (2019) Prasanth Manohar et al. Frontiers in Microbiology
- Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy
- (2019) Thaysa Leite Tagliaferri et al. Frontiers in Cellular and Infection Microbiology
- Endolysin treatment against Staphylococcus aureus in adults with atopic dermatitis: a randomized controlled trial
- (2019) Jill de Wit et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
- (2019) Rebekah M. Dedrick et al. NATURE MEDICINE
- Missing a Phage: Unraveling Tripartite Symbioses within the Human Gut
- (2019) Jeremy J. Barr mSystems
- Therapeutic Potential of an Endolysin Derived from Kayvirus S25-3 for Staphylococcal Impetigo
- (2019) Ichiro Imanishi et al. Viruses-Basel
- Phage-Antibiotic Synergy via Delayed Lysis
- (2018) Minjin Kim et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review
- (2018) Athanasios Kakasis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09
- (2018) Chandini Raina MacIntyre et al. BMC INFECTIOUS DISEASES
- Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
- (2018) Patrick Jault et al. LANCET INFECTIOUS DISEASES
- The fascinating biology behind phage display: Filamentous Phage Assembly
- (2018) Belinda Loh et al. MOLECULAR MICROBIOLOGY
- Phage Therapy: Going Temperate?
- (2018) Rodrigo Monteiro et al. TRENDS IN MICROBIOLOGY
- The disparate effects of bacteriophages on antibiotic-resistant bacteria
- (2018) Clara Torres-Barceló Emerging Microbes & Infections
- Innate Immune Cell Suppression and the Link With Secondary Lung Bacterial Pneumonia
- (2018) David J. Morgan et al. Frontiers in Immunology
- Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia
- (2018) Shigeo Hanada et al. Frontiers in Immunology
- Resolving Viral-Induced Secondary Bacterial Infection in COPD: A Concise Review
- (2018) Hao Wang et al. Frontiers in Immunology
- Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections
- (2017) Antoine Roquilly et al. IMMUNITY
- Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli
- (2017) Nádia Valério et al. VIRUS RESEARCH
- The Transmembrane Morphogenesis Protein gp1 of Filamentous Phages Contains Walker A and Walker B Motifs Essential for Phage Assembly
- (2017) Belinda Loh et al. Viruses-Basel
- Secondary bacterial infections and antibiotic resistance among tungiasis patients in Western, Kenya
- (2017) Ruth Monyenye Nyangacha et al. PLoS Neglected Tropical Diseases
- A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus
- (2017) Hamed Haddad Kashani et al. Frontiers in Cellular and Infection Microbiology
- A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa
- (2017) Mingquan Guo et al. Frontiers in Microbiology
- Secondary Bacterial Infections Associated with Influenza Pandemics
- (2017) Denise E. Morris et al. Frontiers in Microbiology
- Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms
- (2017) Waqas Nasir Chaudhry et al. PLoS One
- Long-term effects of single and combined introductions of antibiotics and bacteriophages on populations of Pseudomonas aeruginosa
- (2016) Clara Torres-Barceló et al. Evolutionary Applications
- Role of phage-antibiotic combination in reducing antibiotic resistance in Staphylococcus aureus
- (2016) Ara Jo et al. FOOD SCIENCE AND BIOTECHNOLOGY
- Synergistic antimicrobial activity of bacteriophages and antibiotics against Staphylococcus aureus
- (2016) Ara Jo et al. FOOD SCIENCE AND BIOTECHNOLOGY
- Prophylactic Bacteriophage Administration More Effective than Post-infection Administration in Reducing Salmonella enterica serovar Enteritidis Shedding in Quail
- (2016) Mosab Ahmadi et al. Frontiers in Microbiology
- Phage therapy against Enterococcus faecalis in dental root canals
- (2016) Leron Khalifa et al. Journal of Oral Microbiology
- Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh
- (2016) Shafiqul Alam Sarker et al. EBioMedicine
- The Role of Viral, Host, and Secondary Bacterial Factors in Influenza Pathogenesis
- (2015) John C. Kash et al. AMERICAN JOURNAL OF PATHOLOGY
- Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria
- (2015) Yves Briers et al. Future Microbiology
- Virus-induced secondary bacterial infection: a concise review
- (2015) Mohamed Hendaus et al. Therapeutics and Clinical Risk Management
- Secondary Bacterial Infection and Empirical Antibiotic Use in Toxic Epidermal Necrolysis Patients
- (2014) Patrick D. Mahar et al. Journal of Burn Care & Research
- mTOR- and HIF-1 -mediated aerobic glycolysis as metabolic basis for trained immunity
- (2014) S.-C. Cheng et al. SCIENCE
- Phage cocktails and the future of phage therapy
- (2013) Benjamin K Chan et al. Future Microbiology
- Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease
- (2012) Patrick Mallia et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Bacteriophage endolysins as novel antimicrobials
- (2012) Mathias Schmelcher et al. Future Microbiology
- Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa
- (2012) Petar Knezevic et al. RESEARCH IN MICROBIOLOGY
- Preventing and treating secondary bacterial infections with antiviral agents
- (2011) Jonathan A McCullers ANTIVIRAL THERAPY
- Viral Infection Augments Nod1/2 Signaling to Potentiate Lethality Associated with Secondary Bacterial Infections
- (2011) Yun-Gi Kim et al. Cell Host & Microbe
- Influenza Virus-Induced Glucocorticoids Compromise Innate Host Defense against a Secondary Bacterial Infection
- (2010) Amanda M. Jamieson et al. Cell Host & Microbe
- Phage Therapy in Clinical Practice: Treatment of Human Infections
- (2010) Elizabeth Kutter et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Influenza Virus Infection Decreases Tracheal Mucociliary Velocity and Clearance ofStreptococcus pneumoniae
- (2009) Lynnelle A. Pittet et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Phage therapy
- (2009) John N. Housby et al. DRUG DISCOVERY TODAY
- Intervention strategies for an influenza pandemic taking into account secondary bacterial infections
- (2009) Andreas Handel et al. Epidemics
- Is phage therapy acceptable in the immunocompromised host?
- (2008) Jan Borysowski et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation